Australia markets closed

Inspire Medical Systems, Inc. (INSP)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
232.27-3.12 (-1.33%)
At close: 04:00PM EST
232.27 +0.17 (+0.07%)
After hours: 04:11PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 6.80B
Enterprise value 6.38B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.70
Price/book (mrq)14.46
Enterprise value/revenue 18.32
Enterprise value/EBITDA -138.55

Trading information

Stock price history

Beta (5Y monthly) 1.55
52-week change 36.99%
S&P500 52-week change 3-15.89%
52-week high 3272.04
52-week low 3142.74
50-day moving average 3200.16
200-day moving average 3205.03

Share statistics

Avg vol (3-month) 3318.48k
Avg vol (10-day) 3287.38k
Shares outstanding 528.89M
Implied shares outstanding 6N/A
Float 828.36M
% held by insiders 11.95%
% held by institutions 198.94%
Shares short (14 Nov 2022) 41.22M
Short ratio (14 Nov 2022) 43.28
Short % of float (14 Nov 2022) 44.32%
Short % of shares outstanding (14 Nov 2022) 44.23%
Shares short (prior month 13 Oct 2022) 41.36M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin -14.47%
Operating margin (ttm)-14.09%

Management effectiveness

Return on assets (ttm)-7.61%
Return on equity (ttm)-14.60%

Income statement

Revenue (ttm)348.35M
Revenue per share (ttm)12.59
Quarterly revenue growth (yoy)77.00%
Gross profit (ttm)200.12M
EBITDA -47.45M
Net income avi to common (ttm)-50.42M
Diluted EPS (ttm)-1.55
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)427.55M
Total cash per share (mrq)14.8
Total debt (mrq)9.13M
Total debt/equity (mrq)1.94
Current ratio (mrq)10.05
Book value per share (mrq)16.32

Cash flow statement

Operating cash flow (ttm)-6.97M
Levered free cash flow (ttm)5.35M